- The key vendors in the Global Gene Expression Market 2015-2019 are Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Qiagen NV and Thermo Fisher Scientific Inc.
London, 23 December 2014: TechNavio, an independent tech-focused global research firm, has announced the publication of its market research report on the Global Gene Expression Market 2015-2019. One of the major trends upcoming in this market is the automation of gene expression profiling. This helps reduce consumption of reagents, and enhances accuracy and productivity in research and drug discovery. The Global Gene Expression market is expected to grow at a CAGR of 11.12 percent during the forecast period of 2014-2019.
Big pharmaceutical and biotechnology companies concentrate on the development of drugs in which gene expression profiling and analysis play important roles. Advances in instrumentation and growing demand for accurate diagnostic technology are propelling the use of gene expression in diagnostics, and drug discovery and development.
“Advanced gene expression tools such as DNA microarray and NGS provide simultaneous analysis of thousands of genes and generation of vast databases,” says Faisal Ghaus, Vice President of TechNavio Research.
“The increased adoption of bioinformatics is the result of the development of high-end bioinformatics tools and technologies.”
To define the market conditions in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
